The collaboration aims to be a key accelerator in the country’s mission to screen and detect patients for pulmonary TB and support the Government of India’s agenda to eliminate TB by 2025
Mylab Discovery Solutions has announced its partnership with Qure.ai to deploy AI technology-enabled chest X-ray for early detection of tuberculosis (TB) and aid in universal lung health. Under the partnership, Mylab’s soon-to-be launched handheld X-Ray device, MyBeam will leverage Qure.ai’s AI software, qXR, to improve the accuracy and speed of TB diagnosis. MyBeam in conjunction with qXR will be an effective screening tool for TB detection and will help improve access to TB testing.
The collaboration aims to be a key accelerator in the country’s mission to screen and detect patients for pulmonary TB and support the Government of India’s agenda to eliminate TB by 2025. The implementation of the AI-enabled Chest X-Ray solutions for TB screening will strengthen access to screening among populations who are at greater risk for this disease.
MyBeam which is a portable X-Ray device, through its investee company Lipomic, is equipped high-frequency technology. It is the latest addition to Mylab’s suite of solutions for screening, detection and prevention of TB. The device offers high performance and greater speed as it acquires images within a few minutes. It’s compact, lightweight and provides expanded clinical coverage. It can be used at resource-limited settings or where there’s a lack of access to equipment. MyBeam will prove to be extremely beneficial for finding TB cases in the most remote settings.
qXR for TB is AI software that uses deep learning algorithms to analyse chest X-rays and accurately identify TB under a minute. qXR is WHO recommended and CE class II certified to be used for preliminary TB screening and gives its interpretation in under a minute. Qure.ai’s lung health suite of products will complement the existing screening and diagnostic pathways and enable a sustained increase in active case findings.
The partnership will have MyBeam integrated with Qure.ai’s AI-enabled computer-assisted detection software, along with its lung health management platform, to evaluate chest X-rays and identify presumptive TB patients. The AI-enabled screening pathway will be crucial for augmenting the current TB screening mechanism and alleviate pressure on the healthcare workforce relative to identification of TB presumptive patients.